None listed
Conditions
Interventions
Radical local treatment (+ hormonal treatment if appropriate) + 3-6 months of Chemotherapy.
Group name:Hormone treatment Type of group
Radical locat treatment (+ hormonal treatment if appropriate)
Sponsors
INTERNATIONAL BREAST CANCER STUDY GROUP - IBCSG,
Eligibility
Inclusion criteria
Inclusion criteria: not contemplated
Exclusion criteria
Exclusion criteria: not contemplated
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcome name:First confirmation of recurrence (local, regional or distant), second primary (including non-breast) tumor, and / or death. Disease-free survival (DFS) is defmed as the time from randomization to local, regional or distant recurrence (including recurrence restricted to the breast after breast conserving treatment), appearance of a second primary tumor, beginning of a new cancer-specific therapy, or death from any cause, whichever occurs first. An in siiu recurrence either in the ipsilateral or in the contralateral breast is not considered a recurrence (but must be reported on the Follow-up Form). Measure:To evaluate the efficacy of adyunvant chemotherapy after radical resection of the first loco regional recurrence of breast cancer. Timepoints:6 weeks ; Outcome name:Overall survival (OS) is defmed as the time from randomization to death from any cause. Systemic relapse is defmed as any recurrent or metastatic disease in sites other than the local mastectomy scar / chest wall / skin, the ipsilateral breast in case of breast conservation, or the ipsilateral axilla and intemal mammary lymph nodes. Measure:Compare the two arms of treatment: survival free of systemic disease and quality of life. Timepoints:6 weeks | — |
Countries
Peru, United States
Outcome results
None listed